Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr 1;2(2):e23828.
doi: 10.4161/jkst.23828.

Targeting the tumor microenvironment: JAK-STAT3 signaling

Affiliations
Review

Targeting the tumor microenvironment: JAK-STAT3 signaling

Eirini Bournazou et al. JAKSTAT. .

Abstract

Persistent JAK-STAT3 signaling is implicated in many aspects of tumorigenesis. Apart from its tumor-intrinsic effects, STAT3 also exerts tumor-extrinsic effects, supporting tumor survival and metastasis. These involve the regulation of paracrine cytokine signaling, alterations in metastatic sites rendering these permissive for the growth of cancer cells and subversion of host immune responses to create an immunosuppressive environment. Targeting this signaling pathway is considered a novel promising therapeutic approach, especially in the context of tumor immunity. In this article, we will review to what extent JAK-STAT3-targeted therapies affect the tumor microenvironment and whether the observed effects underlie responsiveness to therapy.

Keywords: IL-6; JAK-STAT3 signaling; targeted therapies; tumor microenvironment.

PubMed Disclaimer

Figures

None
Figure 1. The role of activated STAT3 and its molecular targets in tumorigenesis.
None
Figure 2. Immunohistochemical (A) and immunofluorescent (B) images showing localization of activated STAT3 (red) on the edge of human breast tumors in association with myeloid (CD33+, green) cells.
None
Figure 3. The STAT3-dependent cytokine network as a regulator of cellular interactions with the tumor stroma.

Similar articles

Cited by

References

    1. Darnell JE., Jr. STATs and gene regulation. Science. 1997;277:1630–5. doi: 10.1126/science.277.5332.1630. - DOI - PubMed
    1. Bromberg J. Stat proteins and oncogenesis. J Clin Invest. 2002;109:1139–42. - PMC - PubMed
    1. Yu H, Jove R. The STATs of cancer--new molecular targets come of age. Nat Rev Cancer. 2004;4:97–105. doi: 10.1038/nrc1275. - DOI - PubMed
    1. Sommer J, Effenberger T, Volpi E, Waetzig GH, Bernhardt M, Suthaus J, et al. Constitutively active mutant gp130 receptor protein from inflammatory hepatocellular adenoma is inhibited by an anti-gp130 antibody that specifically neutralizes interleukin 11 signaling. J Biol Chem. 2012;287:13743–51. doi: 10.1074/jbc.M111.349167. - DOI - PMC - PubMed
    1. Zhang X, Guo A, Yu J, Possemato A, Chen Y, Zheng W, et al. Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T. Proc Natl Acad Sci U S A. 2007;104:4060–4. doi: 10.1073/pnas.0611665104. - DOI - PMC - PubMed